凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06821 凯莱英

交易中 05-07 14:40:04

54.250

-3.250

-5.65%

最高57.950	最低54.000	成交量115.25万
今开56.600	昨收57.500	日振幅6.87%
总市值195.84亿	流通市值14.95亿	总股本3.61亿
成交额6,406万	换手率4.18%	流通股本2,755万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":54.25,"timestamp":1746599915395,"preClose":57.5,"halted":0,"volume":1152500,"delay":0,"floatShares":27553300,"shares":361000000,"eps":2.8889656081783346,"marketStatus":"交易中","change":-3.25,"latestTime":"05-07 14:40:04","open":56.6,"high":57.95,"low":54,"amount":64056777,"amplitude":0.068696,"askPrice":54.5,"askSize":1500,"bidPrice":54.25,"bidSize":900,"shortable":3,"etf":0,"ttmEps":3.0335406164466434,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746605400000},"marketStatusCode":2,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":57.5,"dividendRate":0.021591,"openAndCloseTimeList":[[1746581400000,1746590400000],[1746594000000,1746604800000]],"volumeRatio":1.173618,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":81.65,"timestamp":1746600003000,"preClose":83.02,"halted":0,"volume":3587800,"delay":0,"premium":"-38.13"}},"requestUrl":"/m/hq/s/06821","defaultTab":"news","newsList":[{"id":"2533625091","title":"凯莱英盘中异动 下午盘大幅下挫5.39%报54.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533625091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533625091?lang=zh_cn&edition=full","pubTime":"2025-05-07 14:02","pubTimestamp":1746597774,"startTime":"0","endTime":"0","summary":"2025年05月07日下午盘14时02分，凯莱英股票出现异动，股价急速下挫5.39%。截至发稿，该股报54.400港元/股，成交量102.49万股，换手率3.72%，振幅6.35%。资金方面，该股资金流入1885.38万港元，流出3101.21万港元。凯莱英股票所在的药品行业中，整体跌幅为0.53%。专利摘要显示，本实用新型提供了一种乙烯利中间体连续生产的装置。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507140255975193cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507140255975193cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2533364167","title":"港股异动 | 特朗普预告药品关税 医药股普遍下挫 和铂医药-B(02142)跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533364167","media":"智通财经","labels":["policyRegulatory","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533364167?lang=zh_cn&edition=full","pubTime":"2025-05-07 11:50","pubTimestamp":1746589855,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，医药股早盘普遍下挫，截至发稿，和铂医药-B跌7.06%，报8.04港元；君实生物跌6.38%，报14.98港元；荣昌生物跌6.48%，报38.25港元；药明康德跌3.61%，报60.1港元；凯莱英跌3.74%，报55.35港元。他认为，与世界其他国家相比，美国的药品成本被高估。该命令要求美国食品药品监督管理局简化审查程序，并与美国国内制造商合作，在设施上线之前提供早期支持。特朗普当地时间周一还表示，他将在未来两周内宣布针对药品的关税。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290055.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0052750758.USD","02359","BK1576","159938","LU0708995583.HKD","BK1515","LU2045819591.USD","BK1574","LU2242644610.SGD","BK1161","BK1583","LU2125910500.SGD","09939","BK1191","LU1046422090.SGD","BK1141","06821","02142","LU0320764599.SGD"],"gpt_icon":0},{"id":"2533568569","title":"Norges Bank增持凯莱英(06821)21.84万股 每股作价约56.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533568569","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533568569?lang=zh_cn&edition=full","pubTime":"2025-05-06 18:40","pubTimestamp":1746528013,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月30日，Norges Bank增持凯莱英(06821)21.84万股，每股作价为56.2038港元，总金额约为1227.49万港元。增持后最新持股数目为268.36万股，最新持股比例为9.74%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","BK0239","BK1191","06821","LU1328615791.USD","002821"],"gpt_icon":0},{"id":"2533551622","title":"港股异动 | CRO概念股早盘普跌 维亚生物(01873)跌超4% 药明康德(02359)跌超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533551622","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533551622?lang=zh_cn&edition=full","pubTime":"2025-05-06 10:45","pubTimestamp":1746499512,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股早盘普跌，截至发稿，维亚生物跌4.58%，报1.46港元；药明康德跌3.03%，报62.45港元；康龙化成跌2.07%，报14.16港元；凯莱英跌0.52%，报57.05港元。消息面上，据报道，美国总统特朗普表示，他将在未来两周内宣布对医药产品的关税措施。但从产业链来看，国内医药外包服务公司已成为全球医药产业链重要一环，对美国大药企提升研发效率将更多精力聚焦于后端药品研发制造，实现医药工业生产及价值创造提供了支撑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1289423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","LU2495084118.USD","LU2125910500.SGD","603259","LU2045819591.USD","06821","LU1997244956.HKD","LU0320764599.SGD","01873","LU1046422090.SGD","02359","LU2242644610.SGD","BK1141","LU1997245177.USD","03759","BK1191","BK0216","LU1997245094.SGD","LU0456842615.SGD","BK1583","LU0708995583.HKD","LU0052750758.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2533730858","title":"天津凯莱英取得乙烯利中间体连续生产装置专利，提高乙烯利中间体产物的纯度","url":"https://stock-news.laohu8.com/highlight/detail?id=2533730858","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533730858?lang=zh_cn&edition=full","pubTime":"2025-05-05 15:12","pubTimestamp":1746429174,"startTime":"0","endTime":"0","summary":"金融界2025年5月5日消息，国家知识产权局信息显示，天津凯莱英医药科技发展有限公司取得一项名为“乙烯利中间体连续生产的装置”的专利，授权公告号CN222805155U，申请日期为2024年5月。专利摘要显示，本实用新型提供了一种乙烯利中间体连续生产的装置。提高乙烯利中间体产物的纯度。通过天眼查大数据分析，天津凯莱英医药科技发展有限公司参与招投标项目3次，专利信息128条，此外企业还拥有行政许可7个。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/05151250133838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06821","BK1191","LU1328615791.USD","BK0239","BK0132","002821"],"gpt_icon":0},{"id":"2532890056","title":"每日卖空追踪 | 凯莱英 05月02日卖空量成交2100股，卖空比例为2.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532890056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532890056?lang=zh_cn&edition=full","pubTime":"2025-05-02 16:30","pubTimestamp":1746174636,"startTime":"0","endTime":"0","summary":"凯莱英北京时间05月02日，涨4.08%，卖空量成交2100股，较上一交易日减少93.11%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502163849a6d0e65b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502163849a6d0e65b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2531036835","title":"Norges Bank增持凯莱英4.87万股 每股作价约45.53港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531036835","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531036835?lang=zh_cn&edition=full","pubTime":"2025-04-30 18:47","pubTimestamp":1746010029,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，1月13日，Norges Bank增持凯莱英(06821)4.87万股，每股作价为45.5282港元，总金额约为221.72万港元。增持后最新持股数目为195.07万股，最新持股比例为7.08%。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043018533994e8deb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043018533994e8deb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2531827670","title":"Norges Bank增持凯莱英(06821)5.33万股 每股作价约52.81港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531827670","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531827670?lang=zh_cn&edition=full","pubTime":"2025-04-30 18:30","pubTimestamp":1746009044,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月28日，Norges Bank增持凯莱英(06821)5.33万股，每股作价为52.8074港元，总金额约为281.46万港元。增持后最新持股数目为221.63万股，最新持股比例为8.04%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1288481.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","BK1191","LU1328615791.USD","BK0239","BK0132","002821"],"gpt_icon":0},{"id":"2531270198","title":"凯莱英：公司2024年度营业总收入58.05亿元，同比下降主要系去年同期交付大订单","url":"https://stock-news.laohu8.com/highlight/detail?id=2531270198","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531270198?lang=zh_cn&edition=full","pubTime":"2025-04-29 17:00","pubTimestamp":1745917244,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英(002821)04月29日在投资者关系平台上答复投资者关心的问题。投资者提问：请提供凯莱英2024年报数据凯莱英回复：尊敬的投资者，您好！公司2024年度营业总收入58.05亿元，同比下降主要系去年同期交付大订单，本报告期不再有相关订单所致，如剔除上年同期大订单影响后营业收入同比增长7.40%。公司持续加大业务开拓力度，2024年累计新签订单同比增长约20%。详细财务数据及经营情况请见公司于巨潮资讯网披露的《2024年年度报告》，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900031327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","002821","BK1191","LU1328615791.USD","BK0239","BK0132"],"gpt_icon":0},{"id":"2531280792","title":"凯莱英一季度归母净利润增长15.8%，股价盘中涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531280792","media":"iDoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531280792?lang=zh_cn&edition=full","pubTime":"2025-04-29 13:38","pubTimestamp":1745905081,"startTime":"0","endTime":"0","summary":"4月29日，凯莱英早盘一度涨超10%，截至发稿上涨5.05%，报56.15港元。公司2025年第一季度收入15.41亿元，同比增长10.1%，归母净利润3.27亿元，同比增长15.8%。期内毛利润率为42.5%，新兴业务收入同比增长超80%。华西证券与平安证券均看好公司未来发展前景，认为小分子CDMO及多肽等新业务有望推动业绩快速增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042913392394e6fda9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042913392394e6fda9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821"],"gpt_icon":0},{"id":"2531210385","title":"凯莱英盘中涨超10% 一季度归母净利润同比增长15.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531210385","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531210385?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:53","pubTimestamp":1745895180,"startTime":"0","endTime":"0","summary":"　　凯莱英早盘一度涨超10%，截至发稿，股价上涨5.05%，现报56.15港元，成交额1.01亿港元。　　凯莱英此前发布2025年第一季度报告，期内收入15.41亿元，同比增长10.1%，归母净利润为3.27亿元，同比增长15.8%。毛利润率和归母净利润率分别为42.5%和21.2%。　　华西证券指出，考虑到公司24年新签订单同比增长约20%，以及新业务能力持续建设，判断后续伴随小分子CDMO业务的环比继续改善和新业务逐渐恢复良好增长态势，业绩有望逐渐恢复快速增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-29/doc-ineuuwaa1261573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06821","002821"],"gpt_icon":0},{"id":"2531217793","title":"药明康德Q1业绩亮眼促CRO概念股集体走强，凯莱英涨近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217793","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531217793?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:36","pubTimestamp":1745894160,"startTime":"0","endTime":"0","summary":"药明康德2025年第一季度业绩亮眼，营业收入达96.55亿元，同比增长20.96%，净利润36.72亿元，同比大幅增长89.06%。受此利好消息影响，港股市场CRO板块集体走强，其中凯莱英涨近7%，药明康德涨近6%，维亚生物涨超3%，康龙化成和昭衍新药涨超2%。这一强劲表现不仅提振了投资者信心，也反映了市场对CRO行业前景的乐观预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910382097496244&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910382097496244&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0052750758.USD","LU2125910500.SGD","06821","LU0708995583.HKD","BK1191","LU2045819591.USD","BK1583","603259","LU0320764599.SGD","LU2242644610.SGD","LU1046422090.SGD","02359","BK1576","BK1141"],"gpt_icon":0},{"id":"2531021100","title":"港股异动 | 凯莱英(06821)再涨超10% 一季度业绩实现双位数增长 新兴业务进入加速放量期","url":"https://stock-news.laohu8.com/highlight/detail?id=2531021100","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531021100?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:13","pubTimestamp":1745892816,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凯莱英再涨超10%，截至发稿，涨10.38%，报59港元，成交额6471.35万港元。消息面上，凯莱英此前发布2025年第一季度报告，期内收入15.41亿元，同比增长10.1%，归母净利润为3.27亿元，同比增长15.8%。期内，公司持续加大市场开拓力度及提升业务竞争力，新兴业务实现收入同比增长超80%，毛利率33.05%，较去年同期有较为明显回升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","BK1191","002821","BK0132","BK0239","LU1328615791.USD"],"gpt_icon":0},{"id":"2531123732","title":"创新药概念异动 凯莱英涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531123732","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531123732?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:12","pubTimestamp":1745892720,"startTime":"0","endTime":"0","summary":"人民财讯4月29日电，创新药概念异动，ST香雪涨超8%，泓博医药、凯莱英涨超7%，药明康德、汉商集团、九州通涨超4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910120094e6bb84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042910120094e6bb84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1161","BK1191","06978","BK1574"],"gpt_icon":0},{"id":"2531902211","title":"凯莱英盘中异动 早盘股价大涨5.52%报56.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531902211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531902211?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:56","pubTimestamp":1745891818,"startTime":"0","endTime":"0","summary":"2025年04月29日早盘09时56分，凯莱英股票出现波动，股价急速上涨5.52%。截至发稿，该股报56.400港元/股，成交量43.97万股，换手率1.60%，振幅5.43%。凯莱英股票所在的药品行业中，整体涨幅为0.25%。报告期内，公司实现营业总收入62.85亿元，同比下降23.27%；归母净利润9.49亿元，同比下降58.17%；经营活动产生的现金流量净额为12.54亿元，同比下降64.66%；据报告显示，凯莱英基本每股收益为2.69元，加权平均净资产收益率为5.47%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909565997495366&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909565997495366&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2530422864","title":"凯莱英盘中异动 临近收盘快速拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530422864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530422864?lang=zh_cn&edition=full","pubTime":"2025-04-28 15:34","pubTimestamp":1745825678,"startTime":"0","endTime":"0","summary":"2025年04月28日临近收盘15时34分，凯莱英股票出现异动，股价大幅上涨5.23%。凯莱英股票所在的药品行业中，整体跌幅为0.19%。报告期内，公司实现营业总收入62.85亿元，同比下降23.27%；归母净利润9.49亿元，同比下降58.17%；经营活动产生的现金流量净额为12.54亿元，同比下降64.66%；据报告显示，凯莱英基本每股收益为2.69元，加权平均净资产收益率为5.47%。数据显示，2024年公司加权平均净资产收益率为5.47%，较上年同期下降8.13个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042815343897481e87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042815343897481e87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2530441883","title":"港股异动 | 凯莱英(06821)尾盘涨超4% 一季度纯利增超15% 新兴业务实现收入同比增长超80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530441883","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530441883?lang=zh_cn&edition=full","pubTime":"2025-04-28 15:18","pubTimestamp":1745824717,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凯莱英尾盘涨超4%，截至发稿，涨4.34%，报52.85港元，成交额7578.35万港元。消息面上，凯莱英公布2025年第一季度业绩，营业收入约15.41亿元，同比增长10.1%。归属于上市公司股东的净利润约3.27亿元，同比增长15.83%。公司持续加大市场开拓力度及提升业务竞争力，特别是多肽、寡核苷酸、抗体药物偶联物等增量业务，新兴业务实现收入同比增长超80%，毛利率33.05%，较去年同期有较为明显回升。华西证券指出，公司一季度业绩符合市场预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286230.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06821","002821","BK0239","BK1191","LU1328615791.USD","BK0132"],"gpt_icon":0},{"id":"2530509731","title":"每日卖空追踪 | 凯莱英 04月25日卖空量成交31.39万股，卖空比例为20.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530509731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530509731?lang=zh_cn&edition=full","pubTime":"2025-04-26 00:56","pubTimestamp":1745600198,"startTime":"0","endTime":"0","summary":"凯莱英北京时间04月25日，跌3.25%，卖空量成交31.39万股，较上一交易日减少35.17%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426005642a6c84c98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426005642a6c84c98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2530491552","title":"【私募调研记录】高毅资产调研凯莱英","url":"https://stock-news.laohu8.com/highlight/detail?id=2530491552","media":"证星私募调研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530491552?lang=zh_cn&edition=full","pubTime":"2025-04-25 08:00","pubTimestamp":1745539257,"startTime":"0","endTime":"0","summary":"根据市场公开信息及4月24日披露的机构调研信息，知名私募高毅资产近期对1家上市公司进行了调研，相关名单如下：1）凯莱英 凯莱英2025年一季报显示，公司主营收入15.41亿元，同比上升10.1%；归母净利润3.27亿元，同比上升15.83%；扣非净利润3.05亿元，同比上升20.14%；负债率11.58%，投资收益1027.52万元，财务费用-4493.96万元，毛利率42.54%。高毅资产已经在中国证券投资基金业协会备案，注册地在上海，团队分布在深圳、上海和北京。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042508044394e1a0bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042508044394e1a0bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2530591345","title":"凯莱英授出489.60万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2530591345","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530591345?lang=zh_cn&edition=full","pubTime":"2025-04-25 07:54","pubTimestamp":1745538840,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　凯莱英（06821）公布，公司董事会认为公司《2025 年限制性股票激励计划（草案）修订稿》规定的首次授予条件已经成就，同意确定 2025 年 4 月 24 日为首次授予日，向 648 名激励对象授予 489.60 万股限制性股票。首次授予部分限制性股票授予价格为每股 37.52 元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-25/doc-ineuirkc2820348.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06821","002821","LU1328615791.USD","BK1191","BK0239","BK0132"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.asymchem.com","stockEarnings":[{"period":"1week","weight":0.0277},{"period":"1month","weight":0.0314},{"period":"3month","weight":0.1375},{"period":"6month","weight":-0.0589},{"period":"1year","weight":-0.0888},{"period":"ytd","weight":0.1176}],"compareEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":-0.0082},{"period":"3month","weight":0.1003},{"period":"6month","weight":0.0816},{"period":"1year","weight":0.2198},{"period":"ytd","weight":0.1297}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"凯莱英医药集团（天津）股份有限公司是一家主要从事提供医药外包一站式综合服务的中国公司。该公司的业务包括小分子药物定制研发生产（CDMO）、化学大分子CDMO、临床研究服务、制剂CDMO、生物大分子CDMO、技术输出和合成生物技术。该公司的产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.109045},{"month":2,"riseRate":0.5,"avgChangeRate":0.017669},{"month":3,"riseRate":0.25,"avgChangeRate":-0.034305},{"month":4,"riseRate":0.5,"avgChangeRate":-0.084781},{"month":5,"riseRate":0.5,"avgChangeRate":-0.031846},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.006579},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.032115},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.037196},{"month":9,"riseRate":0.666667,"avgChangeRate":0.190591},{"month":10,"riseRate":0,"avgChangeRate":-0.11689},{"month":11,"riseRate":0.666667,"avgChangeRate":0.030863},{"month":12,"riseRate":0.333333,"avgChangeRate":0.021231}],"exchange":"SEHK","name":"凯莱英","nameEN":"ASYMCHEM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.3","shortVersion":"4.33.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,06821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}